Fennec Pharmaceuticals (FENC) Invested Capital (2010 - 2022)

Fennec Pharmaceuticals (FENC) has 5 years of Invested Capital data on file, last reported at $18.2 million in Q3 2025.

• Quarterly Invested Capital fell 39.31% year-over-year to $18.2 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $54.6 million (down 49.52% YoY) and the FY2024 annual result came in at $18.2 million, down 39.31% from the prior year.
• Invested Capital steadied at $18.2 million in Q3 2025, from $18.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $30.0 million in Q4 2023 to a low of $500000.0 in Q1 2022.
• A 5-year average of $18.2 million and a median of $18.2 million in 2024 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital slumped 80.0% — and 2023, when it jumped 4900.0%.
• Tracing FENC's Invested Capital over 5 years: stood at $5.0 million in 2021, then soared by 400.0% to $25.0 million in 2022, then rose by 20.0% to $30.0 million in 2023, then sank by 39.31% to $18.2 million in 2024, then changed by 0.0% to $18.2 million in 2025.
• The last three Invested Capital figures came in at $18.2 million (Q3 2025), $18.2 million (Q2 2025), and $18.2 million (Q1 2025), per Business Quant data.